Published TCIMAIL newest issue No.196
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 154229-18-2 | Product Number: A2891
Abiraterone Acetate
Purity: >98.0%(T)(HPLC)
Synonyms:
- 3β-17-(3-Pyridyl)androsta-5,16-dien-3-ol Acetate
Product Documents:
Size | Unit Price | Belgium | Japan* | Quantity |
---|---|---|---|---|
200MG |
52,00 €
|
2 | ≥100 |
|
1G |
164,00 €
|
2 | ≥60 |
|
*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).
Product Number | A2891 |
Purity / Analysis Method | >98.0%(T)(HPLC) |
Molecular Formula / Molecular Weight | C__2__6H__3__3NO__2 = 391.56 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Frozen (<0°C) |
Condition to Avoid | Heat Sensitive |
CAS RN | 154229-18-2 |
Reaxys Registry Number | 7314563 |
PubChem Substance ID | 253661226 |
MDL Number | MFCD00934213 |
Specifications
Appearance | White to Light yellow to Light orange powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Nonaqueous Titration) | min. 98.0 % |
Melting point | 145.0 to 149.0 °C |
Specific rotation [a]20/D | -40.0 to -45.0 deg(C=2,EtOH) |
Properties (reference)
Melting Point | 147 °C |
Specific Rotation | -43° (C=2,EtOH) |
GHS
Pictogram | |
Signal Word | Warning |
Hazard Statements | H302 : Harmful if swallowed. H361 : Suspected of damaging fertility or the unborn child. H413 : May cause long lasting harmful effects to aquatic life. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P273 : Avoid release to the environment. P201 : Obtain special instructions before use. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection/ hearing protection. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. |
Related Laws:
RTECS# | BV7992100 |
Transport Information:
HS Number | 2937290000 |
Application
Abiraterone Acetate: A Prodrug of Abiraterone [A2868]
Abiraterone acetate (CB7630) is a prodrug of abiraterone [A2868] which is a selective inhibitor of the steroidogenic enzyme cytochrome P450 17A1 (CYP17A1) which catalyzes two key serial reactions (17α-hydroxylase hydroxylase and 17,20-lyase) in androgen and estrogen biosynthesis. Abiraterone is more potent than ketoconazole [K0045] as an inhibitor of CYP17. Abiraterone acetate is an agent used in combination with prednisone [P1276] in metastatic castration-resistant prostate cancer (mCRPC). (The product is for research purpose only.)
References
- Pharmacology of novel steroidal inhibitors of cytochrome P45017α (17α-hydroxylase/C17–20 lyase)
- Effects of novel 17α-hydroxylase/C17, 20-lyase (P450 17, CYP 17) inhibitors on androgen biosynthesis in vitro and in vivo
- CYP17 inhibition as a hormonal strategy for prostate cancer
- Abiraterone acetate: in metastatic castration-resistant prostate cancer (a review)
- Abiraterone Acetate: A Review of Its Use in Patients with Metastatic Castration-Resistant Prostate Cancer
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.